[{"id":"4cd00ace-eb77-4eb4-8c29-3d41b9d5e4fb","acronym":"","url":"https://clinicaltrials.gov/study/NCT05513612","created_at":"2022-08-24T21:07:38.118Z","updated_at":"2024-07-02T16:35:54.501Z","phase":"Phase 1","brief_title":"Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies","source_id_and_acronym":"NCT05513612","lead_sponsor":"Shanghai Pudong Hospital","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • Autologous CAR-T cells"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/01/2020","start_date":" 08/01/2020","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2023-03-01"}]